Cary Pharmaceuticals is a pharmaceutical development company. The Company is advancing the development of QuitPak®, a patented treatment for smoking cessation, and a novel catheter lock solution to prevent clot formation in catheters.
View Top Employees from Cary Pharmaceuticals Inc.Website | http://www.carypharma.com |
Revenue | $4 million |
Employees | 4 (3 on RocketReach) |
Address | 9903 Windy Hollow Rd, Great Falls, Virginia 22066, US |
Phone | (703) 759-7460 |
Technologies | |
Industry | Pharmaceutical Manufacturing, Manufacturing General, Pharmaceutical, Manufacturing, Health Care |
Competitors | Blue Collar Scientific, LLC., Drug Discovery Alliances, Inc., Formurex, Inc., Regulatory Interlinx Inc, Velesco Pharmaceutical Services |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Cary Pharmaceuticals Inc. employee's phone or email?
The Cary Pharmaceuticals Inc. annual revenue was $4 million in 2024.
Carl Schwan is the CFO of Cary Pharmaceuticals Inc..
3 people are employed at Cary Pharmaceuticals Inc..
Cary Pharmaceuticals Inc. is based in Great Falls, Virginia.
The NAICS codes for Cary Pharmaceuticals Inc. are [325, 32541, 3254, 32].
The SIC codes for Cary Pharmaceuticals Inc. are [283, 28].